8-K 1 dp13599_8k.htm FORM 8-K
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): May 26, 2009

Shire plc
________________________________________________________________________________
(Exact name of registrant as specified in its charter)

Jersey, Channel Islands
________________________________________________________________________________
(State or other jurisdiction of incorporation)

0-29630                                                  98-0601486
(Commission File Number)                (IRS Employer Identification No.)

5 Riverwalk, Citywest Business Campus, Dublin
24, Republic of Ireland
________________________________________________________________________________
(Address of principal executive offices)                              (Zip code)

Registrant's telephone number, including area code               +353 1 429 7700


________________________________________________________________________________
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

[   ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[   ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[   ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[   ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.f13e-4(c))
 

 


Item 8.01.  Other Events

     Shire plc has issued the press release attached hereto as Exhibit 99.01 which is incorporated by reference herein.


Item 9.01.  Financial Statements and Exhibits

                  (d)  Exhibits.  The following exhibit is filed herewith:

99.01               Press Release dated May 26, 2009





SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant  has duly caused  this report to be signed on its behalf by the undersigned hereunto duly authorized.


SHIRE PLC
 
  
By:
/s/ A C Russell
  
  Name: Angus Russell
  
  Title: Chief Executive Officer
  


Dated: May 26, 2009
 
 
 

 
EXHIBIT INDEX
 
Number
Description
 
99.01
Press Release dated May 26, 2009

 
 
 
 
 
Exhibit 99.01
 
 
Press Release
www.shire.com
  
 
 
 
BLOCK LISTING SIX MONTHLY RETURN

 
May 26, 2009 - Shire plc (LSE: SHP, NASDAQ: SHPGY)
 
 
Name of applicant:
Shire plc
Name of scheme:
1996 Executive Share Option Scheme
Period of return:
From:
23 November 2008
To:
22 May 2009
Balance of unallotted securities under scheme(s) from previous return:
82,000
 
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
Nil
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
82,000
 
Name of applicant:
Shire plc
Name of scheme:
2000 Executive Share Option Scheme
Period of return:
From:
23 November 2008
To:
22 May 2009
Balance of unallotted securities under scheme(s) from previous return:
5,900,615
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
203,583
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
5,697,032
 
 
 
Registered in Jersey, No. 99854, 22 Grenville Street, St. Helier, Jersey JE4 8PX
 
 

 
 
Name of applicant:
Shire plc
Name of scheme:
Shire Sharesave Scheme
Period of return:
From:
23 November 2008
To:
22 May 2009
Balance of unallotted securities under scheme(s) from previous return:
76,685
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
44,344
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
32,341
 
Name of applicant:
Shire plc
Name of scheme:
Biochem Pharma Stock Option Plan
Period of return:
From:
23 November 2008
To:
22 May 2009
Balance of unallotted securities under scheme(s) from previous return:
14,000
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):
Nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):
4,778
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:
9,222
 
 
Name of contact:
Tony Guthrie, Deputy Company Secretary
Address of contact:
Hampshire International Business Park
Basingstoke, Hampshire, RG24 8EP
Telephone number of contact:
01256 894746
 
 
 
For further information please contact:
 
Investor Relations
Cléa Rosenfeld (Rest of the World)
+44 1256 894 160
 
Eric Rojas (North America)
+1 617 551 9715
 


 
 
Notes to editors
 
SHIRE PLC
 
Shire’s strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions.  Shire’s in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights.  Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.
 
For further information on Shire, please visit the Company’s website: www.shire.com.